Proteins C and S are vitamin K-dependent proteins with an essential an
ticoagulant function. Protein C exists in an inactive form and is acti
vated by a thrombin-thrombomodulin complex. Protein S combines with pr
otein C and forms a stoichiometric complex which regulates coagulation
in the presence of calcium. As patients with sickle cell disease (SCD
) bear a high risk of developing thrombo-embolic disorders, we studied
the coagulation derangement in 100 patients and 40 normal age- and se
x-matched controls. The patients were clinically assessed and classifi
ed into sickle cell homozygotes (Hb SS), Hb S heterozygotes (Hb AS) an
d double heterozygotes for Hb S/beta(0)-thalassaemia based on haematol
ogical parameters, red cell indices, Hb A(2) and F levels and genetic
studies. The proteins C and S were estimated and related to the type o
f the gene defect. The results showed significantly reduced levels of
proteins C and S in SCD patients with the highest prevalence of defici
ency in patients with a severe disease and frequent episodes of crisis
. However, no significant differences were encountered in the level of
proteins C and S in the same patients during the steady state and dur
ing episodes of crisis. It was concluded that the lower protein C and
S levels in SCD is either due to decreased production or increased con
sumption though this reduction does not seem to play a role in produci
ng thrombo-embolic disorders.